Options traders are making a strong bull case for DOV. The put/call ratio hit 0.20 on May 18 — nearly two standard deviations below the 20-day mean of 0.36. That's the most call-heavy positioning seen in months.
The options skew didn't emerge in a vacuum. A wave of analyst target raises followed Dover's Q1 earnings on April 23. The stock gained nearly 4% on the print. Operating margins expanded 120 basis points year-over-year.
Five firms raised targets in the days after results. Baird went to $279. Citigroup lifted to $253. Oppenheimer raised twice — first to $242, then $250. Barclays moved to $230. The consensus target now sits at $248.53, roughly 18% above the current price of $210.83.
That gap is meaningful. It may be part of what's driving call activity higher.
Short interest has dropped too. SI % FF fell to 2.1% as of May 15 — down 9% over the past week and near its lowest level in the past month. At just over 2% of free float, this is a lightly shorted name.
The borrow market remains extremely loose. Availability stands at 5,447% — meaning there are roughly 54 shares available to borrow for every one already borrowed. The lending pool is wide open.
Cost to borrow ticked up to 0.52%, a 25% rise over the past month. But in absolute terms, that remains very low. This is not a stock under meaningful short-selling pressure.
JP Morgan Asset Management added 4.46 million shares as of April 30 — by far the largest holder move in the snapshot. FMR (Fidelity) added 1.47 million shares. JPMorgan Chase added 750,000. Those are substantial builds from major institutions.
Dover's dividend score ranks at the 94th percentile among peers. The stock trades at 19.2x trailing earnings and 14.6x EV/EBITDA.
See the live data behind this article on ORTEX.
Open DOV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
